The Inter-agency Task Force (IATF) for the Management of Emerging Infectious Diseases organised by the executive of the Philippine Government has approved the recommendations for Covid-19 vaccine clinical trials.

The approval on vaccine development was given in a resolution on the conduct of trials of the sub-technical working group (TWG) led by the Department of Science and Technology (DOST).

DOST Secretary Fortunato de la Peña, in a briefing with Presidential Spokesperson Harry Roque, said the sub-TWG was assisted by the Vaccine Expert Panel.

As per the recommendations, the World Health Organization (WHO) Solidarity Trial will be given priority in sites where clinical trials take place.

De la Peña said that the independent clinical trials will be conducted by companies, and the other one is the WHO Solidarity Trial.

The WHO will be prioritised in case of any competition in a trial site, but authorities will make sure the companies will not be deprived of the sites, De la Peña added.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Subjects for the WHO Solidarity Trial will be recruited from the top 5 to 10 barangays reporting high Covid-19 cases.

De la Peña further added: “Transient residents are discouraged unless they can prove they will stay there for another two years because we need to monitor them.”

The recommendations also state that trial zones will be assigned to independent trials to make sure there will be no competition in recruiting participants.

As agreed by the DOST and the Department of the Interior and Local Government (DILG), local government units (LGUs) will involve in the vaccine clinical trials.

Additionally, barangay volunteers and mobile phones will be used for follow-ups.

The IATF said that the DOH will be responsible for deciding the vaccine and the number of doses to be procured.